Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Recombinant Varicella Vaccine

Home DrugsRecombinant Varicella Vaccine

Recombinant Varicella Vaccine

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Recombinant varicella-zoster virus (VZV) vaccine
Applicant: BEIJING LUZHU BIOTECHNOLOGY CO LTDPriority: 2019
US
Varicella-zoster virus recombinant chimeric protein, and coding gene, recombinant plasmid vector, transformant and vaccine thereof
Applicant: LIAONING CHENGDA BIOTECHNOLOGY CO LTDPriority: 2022
CN
Varicella-zoster virus virus-like particle vaccine gE-eVLP, recombinant adenovirus vector vaccine, mRNA vaccine and preparation method and application thereof
Applicant: MUKE WEIKANG HANGZHOU BIOTECHNOLOGY CO LTDPriority: 2026
CN
Fusion protein IFN alpha-gE-Fc and application thereof in preparation of recombinant varicella-herpes zoster vaccine
Applicant: INST MICROBIOLOGY CASPriority: 2025
CN
Recombinant vaccine from gE, gI, and gB proteins of the varicella-zoster virus for the treatment and prevention of multiple sclerosis
Applicant: SOTELO-MORALES JULIO EPriority: 2004
US
2 publications
RECOMBINANT MULTIVALENT VACCINE
Applicant: GOMI YASUYUKIPriority: 2005
CN
US
2 publications
Varicella vaccine freeze-drying protective agent containing sorbitol component
Applicant: LIAONING MAOKANGYUAN BIO TECHNOLOGY CO LTDPriority: 2013
CN
Method for producing novel freeze-dried live attenuated varicella vaccine
Applicant: BEIJING HEKANGYUAN BIOLOG SCIENCE & TECHNOLOGY CO LTDPriority: 2014
CN